Verificando…
Traducido automáticamente. Dosis y advertencias: consulta el original en inglés. Leer en inglés
Inicio / Registrado en Nigeria / Histolat Tablets

Histolat Tablets

NAFDAC Reg. No. A11-100022 Estupefaciente

Registrado en NAFDAC. Registro activoAs of 31 October 2026 · synced automatically from official sources.
Producto
Histolat Tablets
Número NAFDAC
A11-100022
Principio activo
Levocetirizine Dihydrochloride
Dosis
5 mg
Forma
Tablet
Tamaño del envase
10 x 10's (in PVC-Alu blisters)
Fabricante
No Constan
Solicitante (titular)
Afrab-Chem Limited
Approved
28 Apr 2026
Estado
Inactive Ver en NAFDAC ↗
Registro válido hasta
27 Apr 2031
Alertas de la OMS
No se ha encontrado ninguno
Informes de la comunidad
Ninguno
Tiempos comprobados
0

Pero sobre el medicamento, Levocetirizine dihydrochloride: uses, dosage and brands worldwide

Lo que encontramos

  • Histolat Tablets is on the NAFDAC register with an active registration (A11-100022). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generado automáticamente a partir del registro NAFDAC, QUIÉN alerta y los datos de la comunidad a partir de hoy. Este no es un consejo médico. Siga siempre a su médico o farmacéutico.

How to use Histolat Tablets

Lo que dice el prospecto oficial. Si te lo recetó un médico, sigue la receta. Si el prospecto de tu caja es distinto, manda el de tu caja.

Para quién es

Temporarily relieves these symptoms due to hay fever or other respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat

Cómo tomarlo y con qué frecuencia
  • Adults 65 years of age and older ask a doctor
  • Adults and children 12-64 years of age take 1 tablet (5 mg) once daily in the evening
  • Do not take more than 1 tablet (5 mg) in 24 hours 1/2 tablet (2.5 mg) once daily in the evening may be appropriate for less severe symptoms
  • Children 6-11 years of age take 1/2 tablet (2.5 mg) once daily in the evening
  • Do not take more than 1/2 tablet (2.5 mg) in 24 hours
  • Children under 6 years of age do not use consumers with kidney disease do not use
While you are taking it

drowsiness may occur avoid alcoholic drinks alcohol, sedatives, and tranquilizers may increase drowsiness be careful when driving a motor vehicle or operating machinery

Talk to a doctor first if

ever had trouble urinating or emptying your bladder

Warnings

Do not use if you have kidney disease if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing cetirizine Ask a doctor before use if you have ever had trouble urinating or emptying your bladder When using this product drowsiness may occur avoid alcoholic drinks alcohol, sedatives, and tranquilizers may increase drowsiness be careful when driving a motor vehicle or operating machinery Stop use and ask doctor if you have trouble urinating or emptying your bladder an allergic reaction to this product occurs. Seek medical help right away. …

Posibles efectos secundarios

Stop use and ask doctor if you have trouble urinating or emptying your bladder an allergic reaction to this product occurs. Seek medical help right away.

Pregnancy and breastfeeding

If pregnant or breast-feeding: if breast-feeding: not recommended if pregnant: ask a health professional before use

How to store it

Keep out of reach of children.

Si olvidas una dosis

Tómala en cuanto te acuerdes, salvo que falte poco para la siguiente. En ese caso, sáltate la olvidada. Nunca tomes dos dosis a la vez para compensar. Revisa tu prospecto, porque algunos medicamentos son distintos.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2025-12-10.

Label for levocetirizine dihydrochloride, the active ingredient registered with NAFDAC.

Check your pack of Histolat Tablets

Add the expiry date on your pack for a full Trust Score.

O haz fotos de la caja
Te quedan 3 verificaciones gratis hoy Fuentes oficiales: FDA de EE. UU. · EMA (UE) · NAFDAC · alertas de la OMS

About Histolat Tablets

What is in Histolat Tablets?

Histolat Tablets contains Levocetirizine Dihydrochloride (5 mg), as tablet, according to its NAFDAC registration record.

Is Histolat Tablets registered with NAFDAC?

Yes. Histolat Tablets is listed on the NAFDAC register under registration number A11-100022, and its registration is active as of 31 October 2026.

Has Histolat Tablets been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Histolat Tablets in our automatically synced alert list.

How can I check that my pack of Histolat Tablets is genuine?

Run a free authenticity scan with the NAFDAC number A11-100022, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Histolat Tablets?

Follow your prescription or the leaflet in your pack. The official label says: adults 65 years of age and older ask a doctor adults and children 12-64 years of age take 1 tablet (5 mg) once daily in the evening do not take more than 1 tablet (5 mg) in 24 hours 1/2 tablet (2.5 mg) once daily in the evening may be appropriate for less severe symptoms children 6-11 years of age take 1/2 tablet (2.5 mg) once daily in the evening do not take more than 1/2 tabl…

What is Histolat Tablets used for?

temporarily relieves these symptoms due to hay fever or other respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat (Summarised from the official U.S. FDA label for levocetirizine dihydrochloride. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Histolat Tablets? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.